[go: up one dir, main page]

Shehata et al., 2018 - Google Patents

Pharmaceutical formulation and biochemical evaluation of atorvastatin transdermal patches

Shehata et al., 2018

View PDF
Document ID
1685161057876755160
Author
Shehata T
Mohafez O
Hanieh H
Publication year
Publication venue
Indian J. Pharm. Educ. Res

External Links

Snippet

Atorvastatin is a lipid lowering agent and widely used to treat hypercholestermia. However following oral administration, the bioavailability of the drug is only 12% due to extensive first pass metabolism. The aim of the current research was to formulate ATO-transdermal …
Continue reading at pdfs.semanticscholar.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
    • A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Shehata et al. Pharmaceutical formulation and biochemical evaluation of atorvastatin transdermal patches
Shanker et al. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets
DE60318035T2 (en) POLYMER MICROEMULSIONS
Prabhu et al. Formulation development and investigation of domperidone transdermal patches
Mishra et al. Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasis
Hassan et al. Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron
Hanif et al. Enhancement of oral bioavailability of ibandronate through gastroretentive raft forming drug delivery system: in vitro and in vivo evaluation
Abu-Rumman et al. Development and in vitro appraisal of Soluplus® and/or Carbopol® 971 buccoadhesive patches releasing atorvastatin
Balaji et al. Formulation and evaluation of mucoadhesive buccal films of atorvastatin using natural protein
Rao et al. Mucoadhesive biphasic minitablets of cefuroxime axetil: Formulation development, characterization and in vivo bioavailability study
Morkhade et al. Design and evaluation of dental films of PEGylated rosin derivatives containing sparfloxacin for periodontitis
Hafiz et al. Development of cervix-targeted hydrogel carrier for carboplatin-loaded nanosponges: in-vitro and ex-vivo evaluation
Himabindu et al. Formulation and in-vitro evaluation of mucoadhesive buccal patches of cyproheptadine hydrochloride
Chevala et al. Design and development of fluoxetine hydrochloride oro flash films to alleviate major depressive disorder
Kumar et al. Formulation and in-vitro evaluation of terbinafine HCL transdermal patches
Kumar et al. Formulation and evaluation of buccal patches of venlafaxine
Padsala et al. FORMULATION, EVALUATION AND OPTIMIZATION OF MUCOADHESIVE BUCCAL TABLET OF SIMVASTATIN.
Pokale et al. Design, Development and Evaluation of Fast Dissolving Buccal Film of Norethisterone
Assaf et al. Design and evaluation of transdermal delivery system containing tamsulosin hydrochloride
Mohabe et al. Preparation and evaluation of captopril transdermal patches
Yamsani et al. Development of mucoadhesive patches for buccal administration of prochlorperazine: evaluation of in vitro release and mechanical properties
Shivanand et al. Mucoadhessive bilayered buccal tablets of tizanidine hydrochloride
Reddy et al. Formulation and in vitro evaluation of buccal tablets of piroxicam
Birla et al. Formulation and evaluation of quick dissolving films of promethazine hydrochloride
Banu et al. Formulation and evaluation of transdermal drug delivery systems of ivabradine hydrochloride